Hypoxia-inducible factor 1 (HIF-1) in cancer

European Journal of Surgical Oncology

Volumn 30, Issue 5, 2004, Pages 465-468

  Quintero, M ^b   Mackenzie, N ^a   Brennan, Peter A ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Hypoxia inducible factor; Review

Indexed keywords

2 METHOXYESTRADIOL; ERYTHROPOIETIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CELL INVASION; CELL SURVIVAL; DRUG TARGETING; ENDOMETRIUM CANCER; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; HYPOXIA; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 2542569400     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.03.008     Document Type: Review

References (34)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer inst 1990;82:4-6.
2. Moulder JE, Rockwell S. Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 1987;5:313-341.
3. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13:139-168.
4. 2 tension. Am J Physiol 1996;271: C1172-1180.
5. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-1340.
6. Wang GL, Semenza GL. General involvement of hypoxia inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993;90:4304-4308.
7. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducibie transcription factor depends primarily upon redox-sensitive stabilization of its α-subunit. J Biol Chem 1996;271:32253-32259.
8. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999;59:5830-5835.
9. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α. is a marker for an unfavourable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;88:2606-2618.
10. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH et al. Expression of hypoxia-inducibte factor-161: 2911-2916.
11. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlewaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infaction. N Engl J Med 2000; 342:626-633.
12. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677-684.
13. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15: 551-578.
14. An FQ, Matsuda M, Fujii H, Matsumoto Y. Expression of vascular endothelial growth factor in specimens of hepatocellular carcinoma. J Cancer Res Clin Oncol 2000;126: 153-160.
15. Makino Y, Kanopka A, Wilson WJ, Tanaka H, Poellinger L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of thehypoxia-inclucible factor-3α locus. J Biol Chem 2002;277:32405-32408.
16. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. The tumor suppressor protein VHL targets hypoxia inducible factors for oxygen dependent proteolysis. Nature 1999;399:271-275.
17. Ryan HE, Lo J, Johnson RS. HIF-1 is required for solid tumour formation and embryonic vascularisation. EMBO J 1998;17: 3005-3015.
18. Burri P. Significant correlation of hypoxia-inducible factor 1α with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56: 494-501.
19. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M et al. Overexpression of hypoxia-inducible factor 1α is associated with an unfavourable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8:1831-1837.
20. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducibte factor 1α in epithelial. ovarian tumours: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001;7:1661-1668.
21. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI. Tumor and Angiogenesis Research Group. Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma 2002;95:1055-1063.
22. Takahashi R, Tanaka S, Hiyama T, Ito M, Kitadai Y, Sumii M et al. Hypoxia-inducible factor-1α expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 2003;10:797-802.
23. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J, Wykoff CC et al. Hypoxia-inducible factor (HIF-1A and HIF-2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head and neck cancer. Int J Radiat Oncol Biol Phys 2002;53:1192-1202.
24. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001; 85:881-890.
25. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K et al. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgical resected patients. Cancer Res 2002;62: 2493-2497.
26. Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000;20:1527-1533.
27. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998;392:405-408.
28. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97:9082-9087.
29. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
30. Semenza GL. Involvement of hypoxia inducible factor-1 in human cancer. Intern Med 2002;41:79-83.
31. Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E et al. The hypoxia-inducible factor-1α is a negative factor for tumor therapy. Oncogene 2003;22:3213-3220.
32. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. HSP90 regulates a von Hippel-Lindau-independent hypoxia-inducible factor-1α-degradative pathway. J Biol Chem 2002;277:29936-29944.
33. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003;3:363-375.
34. Vincent Ka, Feron O, Kelly RA. Harnessing the response to tissue hypoxia: HIF-1 and therapeutic angiogenesis. Trends Cardiovasc Med 2002;12:362-367.